Spontaneous regression of the inhibitor against the coagulation factor XIII A subunit in acquired factor XIII deficiency

• References

• 1 Ajzner E, Schlammadinger A, Kerenyi A. et al. Severe bleeding complications caused by an autoanti-body against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency.. Blood 2009; 113: 723-725.
• 2 Tosetto A, Castaman G, Rodeghiero F. Acquired plasma factor XIII deficiencies.. Haematologica 1993; 78: 5-10.
• 3 Souri M, Koseki-Kuno S, Takeda N. et al. Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice.. Int J Hematol 2008; 87: 60-68.
• 4 Standeven KF, Ariens RA, Whitaker P. et al. The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation.. Diabetes 2002; 51: 189-197.
• 5 Delgado J, Jimenez-Yuste V, Hernandez-Navarro F. et al. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors.. Br J Haematol 2003; 121: 21-35.
• 6 Huth-Kuhne A, Baudo F, Collins P. et al. International recommendations on the diagnosis and treatment of patients with acquired haemophilia A.. Haematologica 2009; 94: 566-575.
• 7 Lottenberg R, Kentro TB, Kitchens CS. Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy.. Arch Intern Med 1987; 147: 1077-1081.